World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
85
Citations
51716
World Ranking
1289
National Ranking
669

Medicine

D-Index
85
Citations
51788
World Ranking
14340
National Ranking
7249

Kathrin U. Jansen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Kathrin U. Jansen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 315 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Kathrin U. Jansen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Kathrin U. Jansen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 85 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Kathrin U. Jansen is affiliated with Pfizer in the United States and has a significant body of research in medicine, focusing extensively on epidemiology, infectious diseases, immunology, pulmonary and respiratory medicine, and public health. Their research contributions span multiple specialized subfields and main topics related to respiratory infections and vaccine development.

The scientist has contributed notably to the following main topics:

  • Respiratory viral infections research
  • Pneumonia and Respiratory Infections
  • Viral gastroenteritis research and epidemiology
  • SARS-CoV-2 and COVID-19 Research
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Clostridium difficile and Clostridium perfringens research
  • Influenza Virus Research Studies

Jansen has published in several frequent venues, including:

  • New England Journal of Medicine
  • The Journal of Infectious Diseases
  • Open Forum Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases

Among recent papers authored or coauthored by Jansen are:

  • "Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates" (2020, New England Journal of Medicine)
  • "Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants" (2023, New England Journal of Medicine)
  • "BNT162b vaccines protect rhesus macaques from SARS-CoV-2" (2021, Nature)
  • "Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age" (2021, New England Journal of Medicine)
  • "Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults" (2023, New England Journal of Medicine)

Jansen frequently collaborates with fellow researchers, with numerous coauthored publications alongside:

  • William C. Gruber
  • Kena A. Swanson
  • Daniel A. Scott
  • Alejandra Gurtman
  • David Cooper

Best Publications

  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

    Fernando P. Polack;Stephen J. Thomas;Nicholas Kitchin;Judith Absalon

  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.

    Edward E. Walsh;Robert W. Frenck;Ann R. Falsey;Ann R. Falsey;Nicholas Kitchin

  • COVID-19 vaccine BNT162b1 elicits human antibody and T H 1 T cell responses.

    Ugur Sahin;Alexander Muik;Evelyna Derhovanessian;Isabel Vogler

  • A controlled trial of a human papillomavirus type 16 vaccine.

    Laura A. Koutsky;Kevin A. Ault;Cosette M. Wheeler;Darron R. Brown

  • Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

    Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta;Rosires P. Andrade

  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.

    Mark J. Mulligan;Kirsten E. Lyke;Nicholas Kitchin;Judith Absalon

  • Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

    Marc J.M. Bonten;Susanne M. Huijts;Marieke Bolkenbaas;Chris Webber

  • Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.

    Robert W Frenck;Nicola P Klein;Nicholas Kitchin;Alejandra Gurtman

  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.

    Stephen J. Thomas;Edson D. Moreira;Nicholas Kitchin;Judith Absalon

  • BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

    Ugur Sahin;Alexander Muik;Isabel Vogler;Evelyna Derhovanessian

  • Turning the corner on therapeutic cancer vaccines

    Robert E. Hollingsworth;Kathrin Jansen

  • Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial.

    Constance Mao;Laura A. Koutsky;Kevin A. Ault;Cosette M. Wheeler

  • BNT162b vaccines protect rhesus macaques from SARS-CoV-2.

    Annette B. Vogel;Isis Kanevsky;Ye Che;Kena A. Swanson

  • CD21 is a ligand for CD23 and regulates IgE production.

    Jean-Pierre Aubry;Sibylle Pochon;Pierre Graber;Kathrin U. Jansen

  • Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

    Luisa L. Villa;Kevin A. Ault;Anna R. Giuliano;Ronaldo L.R. Costa

  • The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes

    Joseph G. Joyce;Jwu-Sheng Tung;Craig T. Przysiecki;James C. Cook

  • Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.

    Emmanuel B. Walter;Kawsar R. Talaat;Charu Sabharwal;Alejandra Gurtman

  • Neutralizing Activity of BNT162b2-Elicited Serum.

    Yang Liu;Jianying Liu;Hongjie Xia;Xianwen Zhang

  • A Novel Staphylococcus aureus Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine S. aureus Sepsis Model

    Nelly A. Kuklin;Desmond J. Clark;Susan Secore;James Cook

  • SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.

    Ann R Falsey;Robert W Frenck;Edward E Walsh;Nicholas Kitchin

Frequent Co-Authors

Annaliesa S. Anderson
Annaliesa S. Anderson Pfizer (United States)
William C. Gruber
William C. Gruber Pfizer (United States)
David A. Cooper
David A. Cooper University of New South Wales
Daniel A. Scott
Daniel A. Scott Pfizer (United States)
Philip R. Dormitzer
Philip R. Dormitzer Pfizer (United States)
Pei-Yong Shi
Pei-Yong Shi GlaxoSmithKline (United Kingdom)
Robert W. Frenck
Robert W. Frenck Cincinnati Children's Hospital Medical Center
Laura A. Koutsky
Laura A. Koutsky University of Washington
Ugur Sahin
Ugur Sahin Johannes Gutenberg University of Mainz
Ann R. Falsey
Ann R. Falsey University of Rochester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, branching into nursing specialties like Psychiatric-Mental Health Nurse Practitioner (PMHNP) programs can be a natural extension. Many students seek the what is the easiest np program to ensure a manageable balance between coursework and clinical training. This is particularly important for working professionals aiming to advance their careers efficiently.

Online PMHNP programs vary widely, but students often consider options with strong support systems, such as those highlighted in the top online pmhnp programs. These programs usually provide excellent clinical placement rates, a crucial factor for hands-on experience and licensure.

Cost is another key factor when selecting a program. For those mindful of tuition fees, reviewing the cheapest online pmhnp certificate programs can make advanced education more accessible. Affordable programs still maintain quality, enabling graduates to enter the workforce without overwhelming debt.

Career pathways following these degrees often lead to competitive salaries. Understanding compensation trends, such as the dnp salary by state, can help prospective students make informed decisions about where to train and ultimately practice.

Best Scientists Citing Kathrin U. Jansen

Trending Scientists

Recently Published Articles